Read this company snapshot
Daily valuation snapshot
PepGen Inc. Common Stock: source evidence dated 2026-10-09.
- Daily close (USD)
- $2.62
- Market capitalization (USD)
- $181,459,934.54
- Price / earnings (TTM)
- Not reported
- Price / book
- 1.52
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PEPG in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research PEPG in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing PEPG with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $2.62 |
| Market capitalization (USD) | $181,459,934.54 |
| Price / earnings (TTM) | Not reported |
| Price / book | 1.52 |
No matching rows. Clear the filter to see all records.
Read PEPG's valuation metrics
Company size
PepGen Inc. Common Stock's recorded market capitalization is $181,459,934.54. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
PEPG's recorded price-to-book ratio is 1.52. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research PepGen Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about PEPG. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow PEPG's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.